Your browser doesn't support javascript.
loading
Severe atopic dermatitis in a 21-month-old boy successfully treated with dupilumab.
Mazzoni, Daniel; Lobo, Yolanka; Levitt, David; Wheller, Laura.
Afiliação
  • Mazzoni D; Department of Dermatology, Queensland Children's Hospital, Brisbane, Queensland, Australia.
  • Lobo Y; Department of Dermatology, Queensland Children's Hospital, Brisbane, Queensland, Australia.
  • Levitt D; Department of General Paediatrics, Queensland Children's Hospital, Brisbane, Queensland, Australia.
  • Wheller L; Department of General Paediatrics, Queensland Children's Hospital, Brisbane, Queensland, Australia.
Pediatr Dermatol ; 39(4): 606-608, 2022 Jul.
Article em En | MEDLINE | ID: mdl-35575257
ABSTRACT
While dupilumab has emerged as a novel targeted systemic treatment for severe AD, efficacy and safety-based data in young children are limited. We discuss the case of a 21-month-old child with severe recalcitrant atopic dermatitis successfully treated with dupilumab.
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dermatite Atópica Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dermatite Atópica Idioma: En Ano de publicação: 2022 Tipo de documento: Article